Volume 18, Issue 2 (6-2026)                   IJDO 2026, 18(2): 88-97 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karkehabadi S, Matinhomaee H, Dehghan Ghahfarokhi S. Effect of Resistance and Interval Training on Serum Melatonin and Expression of Its Receptors (MTNR1A and MTNR1B) in the Pancreas Tissue of Diabetic Rats. IJDO 2026; 18 (2) :88-97
URL: http://ijdo.ssu.ac.ir/article-1-1036-en.html
Department of Exercise physiology, CT.C, Islamic Azad University, Tehran, Iran.
Abstract:   (162 Views)
Objective: In addition to controlling seasonal and circadian rhythms, melatonin has been recognized as a potential gene associated with type 2 diabetes (T2D). This study aimed to investigate the impact of resistance and interval training on serum melatonin and its receptors expression (MTNR1A, MTNR1B) in pancreatic tissue of type 2 diabetic rats.
Materials and Methods: To achieve this, T2D was established in 21 male Wistar rats through an 8-week high-fat diet followed by an intraperitoneal injection of STZ (25 ml/kg), then were divided to control (no exercise), resistance (resistance training), and interval (interval training) groups. Exercise interventions lasted 8 weeks (5 time/weekly). Fasting glucose, serum insulin and melatonin, beta cell function, MTNR1A and MTNR1B expression in pancreatic tissue were assessed 48 hours following lasting exercise and analyzed among groups using a one-way ANOVA test.
Results: Both resistance and interval training led to significant increase in insulin and beta cell function and significant decrease in glucose, serum melatonin, MTNR1A and MTNR1B expression in pancreatic tissue compared with control group (P< 0.05). Significant difference were not observed in all variables between interval and resistance groups (P> 0.05).
Conclusion: Resistance and interval training are associated with increased insulin in T2D rats, and this improvement may be attributed to decreased melatonin and its receptor expression in pancreatic beta cells. Additional research is required to elucidate alternative mechanisms that contribute to elevated insulin levels.
 
Full-Text [PDF 854 kb]   (57 Downloads)    
Type of Study: Research | Subject: Special
Received: 2025/12/2 | Accepted: 2026/05/20 | Published: 2026/06/1

References
1. Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G,et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal transduction and targeted therapy. 2024;9(1):262. [DOI:10.1038/s41392-024-01951-9]
2. Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR. Beta‐cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10‐year follow‐up of the Belfast Diet Study. Diabetic Medicine. 1998;15(4):290-6. https://doi.org/10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M [DOI:10.1002/(SICI)1096-9136(199804)15:43.0.CO;2-M]
3. Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Molecular and cellular endocrinology. 2009;297(1-2):10-7. [DOI:10.1016/j.mce.2008.10.002]
4. Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annual review of pharmacology and toxicology. 2016;56(1):361-83. [DOI:10.1146/annurev-pharmtox-010814-124742]
5. Peschke E, Frese T, Chankiewitz E, Peschke D, Preiss U, Schneyer U, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin‐receptor status. Journal of pineal research. 2006;40(2):135-43. [DOI:10.1111/j.1600-079X.2005.00287.x]
6. Peschke E, Mühlbauer E. New evidence for a role of melatonin in glucose regulation. Best practice & research Clinical endocrinology & metabolism. 2010;24(5):829-41. [DOI:10.1016/j.beem.2010.09.001]
7. Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, Spégel P, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature genetics. 2009 Jan;41(1):82-8. [DOI:10.1038/ng.288]
8. Mühlbauer E, Peschke E. Evidence for the expression of both the MT1‐and in addition, the MT2‐melatonin receptor, in the rat pancreas, islet and β‐cell. Journal of pineal research. 2007;42(1):105-6. [DOI:10.1111/j.1600-079X.2006.00399.x]
9. Ramracheya RD, Muller DS, Squires PE, Brereton H, Sugden D, Huang GC, et al. Function and expression of melatonin receptors on human pancreatic islets. Journal of pineal research. 2008;44(3):273-9. [DOI:10.1111/j.1600-079X.2007.00523.x]
10. Tan X, Ciuculete DM, Schiöth HB, Benedict C. Associations between chronotype, MTNR1B genotype and risk of type 2 diabetes in UK Biobank. Journal of internal medicine. 2020;287(2):189-96. [DOI:10.1111/joim.12994]
11. Li C, Qiao B, Zhan Y, Peng W, Chen ZJ, Sun L, et al. Association between genetic variations in MTNR1A and MTNR1B genes and gestational diabetes mellitus in Han Chinese women. Gynecologic and obstetric investigation. 2013;76(4):221-7. [DOI:10.1159/000355521]
12. Shaaban Z, Khoradmehr A, Amiri-Yekta A, Nowzari F, Jafarzadeh Shirazi MR, Tamadon A. Pathophysiologic Mechanisms of Insulin Secretion and Signaling‐Related Genes in Etiology of Polycystic Ovary Syndrome. Genetics research. 2021;2021(1):7781823. [DOI:10.1155/2021/7781823]
13. Peschke E. Melatonin, endocrine pancreas and diabetes. Journal of pineal research. 2008;44(1):26-40. [DOI:10.1111/j.1600-079X.2007.00519.x]
14. Karimi M, Eizadi M. The effect of interval training on FOXO1 expression in pancreas tissue of diabetic rats with high fat diet and STZ. Razi Journal of Medical Science. 2019;26(6):95-104.(in Persian)
15. Eizadi M, Ravasi A, Soory R, Baesi K, Choobineh S. The effect of three months of resistance training on TCF7L2 expression in pancreas tissues of type 2 diabetic rats. Avicenna Journal of Medical Biochemistry. 2016;4(1):e34014. [DOI:10.17795/ajmb-34014]
16. Eizadi M, Soory R, Ravasi A, Baesy K, Choobineh S. Relationship between TCF7L2 relative expression in pancreas tissue with changes in insulin by high intensity interval training (HIIT) in type 2 diabetes rats. Journal of Shahid Sadoughi University of Medical of Sciences. 2017;24(12):981-93.(in Persian)
17. Rashidi M, Eizadi M. The effect of an interval exercise period (HIIT) on MTNR1B gene expression, insulin and glucose levels in type 2 diabetic rats.Journal of Knowledge & Health. 2019; 14(1), 28-35.(in Persian)
18. Eizadi M, Mirakhori Z, Farajtabar BS. Effect of 8-Week Interval Training on Protein Tyrosine Phosphatase 1B Expression in Gastrocnemius Muscle and Insulin Resistance in Rats with Type 2 Diabetes. Avicenna Journal of Medical Biochemistry. 2019; 7(2):51-56. [DOI:10.34172/ajmb.2019.09]
19. Eizadi M, Mirakhori Z, Amini A. The effect of 8 week resistance training on IRS 1 gene expression in gastrocnemius muscle and glycemic profile in diabetes rats. Archives of Medical Laboratory Sciences. 2019;5(1):23-30.
20. Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY. Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. The Journal of Clinical Endocrinology & Metabolism. 1990;71(6):1447-53. [DOI:10.1210/jcem-71-6-1447]
21. Lopes WA, Leite N, da Silva LR, Brunelli DT, Gáspari AF, Radominski RB, et al. Effects of 12 weeks of combined training without caloric restriction on inflammatory markers in overweight girls. Journal of sports sciences. 2016;34(20):1902-12. [DOI:10.1080/02640414.2016.1142107]
22. Maltais ML, Perreault K, Courchesne-Loyer A, Lagacé JC, Barsalani R, Dionne IJ. Effect of resistance training and various sources of protein supplementation on body fat mass and metabolic profile in sarcopenic overweight older adult men: a pilot study. International journal of sport nutrition and exercise metabolism. 2016;26(1):71-7. [DOI:10.1123/ijsnem.2015-0160]
23. Vancea DM, Vancea JN, Pires MI, Reis MA, Moura RB, Dib SA. Effect of frequency of physical exercise on glycemic control and body composition in type 2 diabetic patients. Arquivos brasileiros de cardiologia. 2009;92:23-30. [DOI:10.1590/S0066-782X2009000100005]
24. Norman BM, Cecilia Ad P. Role of AKT/mTORC1 pathway in pancreatic β-cell proliferation. Colombia Medica. 2012; 43(3): 235-243. [DOI:10.25100/cm.v43i3.783]
25. Park S, Hong SM, Lee JE, Sung SR. Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic β-cell function and mass through IRS2 in diabetic rats. Journal of applied physiology. 2007;103(5):1764-71. [DOI:10.1152/japplphysiol.00434.2007]
26. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance β-cell function in type 2 diabetes. American Journal of Physiology-Endocrinology and Metabolism. 2004;287(5):E1024-31. [DOI:10.1152/ajpendo.00056.2004]
27. Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel et al. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism. 1990;70(6):1594-602. [DOI:10.1210/jcem-70-6-1594]
28. Eizadi M, Behboudi L, Zahedmanesh F, Afsharmand Z. Effect of acute and chronic exercise on beta-cell function in diabetic patients. Journal of Knowledge & Health in Basic Medical Sciences. 2012; 6(4): 15-19.
29. Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, et al. FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell metabolism. 2005;2(3):153-63. [DOI:10.1016/j.cmet.2005.08.004]
30. Behkar M, Eizadi M, Sedaghaty S, Kazemzadeh Y, Moslehi M. Effects of High-Intensity Interval Training on Transcription Factor 7-Like 2/Glucagon-Like Peptide-1 Axis in Pancreatic Tissue of Obese Diabetic Rats. Medical Laboratory Journal. 2023;17(3):15-21. [DOI:10.61186/mlj.17.3.15]
31. Behkar M, Eizadi M, Sedaghaty S, Kazemzadeh Y, Moslehi M. Impact of high-intensity interval training on GLP-1R/PKBα axis in pancreatic tissue of diabetic rats induced by high-fat diet and STZ. Iranian Journal of Diabetes and Obesity. 2023;15(4):201-7. [DOI:10.18502/ijdo.v15i4.14553]
32. Been LF, Hatfield JL, Shankar A, Aston CE, Ralhan S, Wander GS, et al. A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: genetic risk is modulated by obesity. Nutrition, Metabolism and Cardiovascular Diseases. 2012;22(11):944-51. [DOI:10.1016/j.numecd.2011.01.006]
33. Mühlbauer E, Albrecht E, Bazwinsky‐Wutschke I, Peschke E. Melatonin influences insulin secretion primarily via MT1 receptors in rat insulinoma cells (INS‐1) and mouse pancreatic islets. Journal of pineal research. 2012;52(4):446-59. https://doi.org/10.1111/j.1600-079X.2011.00959.x [DOI:10.1111/j.1600-079X.2012.00959.x]
34. Bazwinsky‐Wutschke I, Wolgast S, Mühlbauer E, Albrecht E, Peschke E. Phosphorylation of cyclic AMP‐response element-binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β‐cells (INS‐1). Journal of pineal research. 2012;53(4):344-57. [DOI:10.1111/j.1600-079X.2012.01004.x]
35. Peschke E, Hofmann K, Pönicke K, Wedekind D, Mühlbauer E. Catecholamines are the key for explaining the biological relevance of insulin-melatonin antagonisms in type 1 and type 2 diabetes. Journal of Pineal Research. 2012;52(4):389-96. [DOI:10.1111/j.1600-079X.2011.00951.x]
36. Li Y, Wu H, Liu N, Cao X, Yang Z, Lu B, et al. Melatonin exerts an inhibitory effect on insulin gene transcription via MTNR1B and the downstream Raf 1/ERK signaling pathway. International journal of molecular medicine. 2018;41(2):955-61. [DOI:10.3892/ijmm.2017.3305]
37. Ramracheya RD, Muller DS, Squires PE, Brereton H, Sugden D, Huang GC, et al. Function and expression of melatonin receptors on human pancreatic islets. Journal of pineal research. 2008;44(3):273-9. [DOI:10.1111/j.1600-079X.2007.00523.x]
38. Vanecek J. Cellular mechanisms of melatonin action. Physiological reviews. 1998;78(3):687-721. [DOI:10.1152/physrev.1998.78.3.687]
39. Mulder H. Melatonin signalling and type 2 diabetes risk: too little, too much or just right?. Diabetologia. 2017;60(5):826-9. [DOI:10.1007/s00125-017-4249-8]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb